Renaissancere Holdings Earnings Calls
| Release date | Oct 28, 2025 |
| EPS estimate | $9.97 |
| EPS actual | $19.39 |
| EPS Surprise | 94.48% |
| Revenue estimate | 2.333B |
| Revenue actual | 3.148B |
| Revenue Surprise | 34.95% |
| Release date | Jul 23, 2025 |
| EPS estimate | $9.90 |
| EPS actual | $17.67 |
| EPS Surprise | 78.48% |
| Revenue estimate | 1.925B |
| Revenue actual | 3.186B |
| Revenue Surprise | 65.52% |
| Release date | Apr 23, 2025 |
| EPS estimate | -$1.17 |
| EPS actual | $3.50 |
| EPS Surprise | 399.79% |
| Revenue estimate | 3.276B |
| Revenue actual | 3.453B |
| Revenue Surprise | 5.39% |
| Release date | Jan 28, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | 2.279B |
Last 4 Quarters for Renaissancere Holdings
Below you can see how RNR-PG performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jan 28, 2025 |
| Price on release | $16.99 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Jan 22, 2025 | $16.69 |
| Jan 23, 2025 | $16.75 |
| Jan 24, 2025 | $16.89 |
| Jan 27, 2025 | $17.15 |
| Jan 28, 2025 | $16.99 |
| Jan 29, 2025 | $16.77 |
| Jan 30, 2025 | $16.85 |
| Jan 31, 2025 | $16.61 |
| Feb 03, 2025 | $16.50 |
| 4 days before | 1.77% |
| 4 days after | -2.86% |
| On release day | -1.27% |
| Change in period | -1.14% |
| Release date | Apr 23, 2025 |
| Price on release | $15.78 |
| EPS estimate | -$1.17 |
| EPS actual | $3.50 |
| EPS surprise | 399.79% |
| Date | Price |
|---|---|
| Apr 16, 2025 | $15.62 |
| Apr 17, 2025 | $15.47 |
| Apr 21, 2025 | $15.44 |
| Apr 22, 2025 | $15.57 |
| Apr 23, 2025 | $15.78 |
| Apr 24, 2025 | $15.85 |
| Apr 25, 2025 | $15.85 |
| Apr 28, 2025 | $15.85 |
| Apr 29, 2025 | $15.80 |
| 4 days before | 1.02% |
| 4 days after | 0.127% |
| On release day | 0.444% |
| Change in period | 1.15% |
| Release date | Jul 23, 2025 |
| Price on release | $15.80 |
| EPS estimate | $9.90 |
| EPS actual | $17.67 |
| EPS surprise | 78.48% |
| Date | Price |
|---|---|
| Jul 17, 2025 | $15.90 |
| Jul 18, 2025 | $15.78 |
| Jul 21, 2025 | $15.82 |
| Jul 22, 2025 | $15.77 |
| Jul 23, 2025 | $15.80 |
| Jul 24, 2025 | $15.81 |
| Jul 25, 2025 | $15.86 |
| Jul 28, 2025 | $15.79 |
| Jul 29, 2025 | $15.88 |
| 4 days before | -0.629% |
| 4 days after | 0.506% |
| On release day | 0.0633% |
| Change in period | -0.126% |
| Release date | Oct 28, 2025 |
| Price on release | $16.97 |
| EPS estimate | $9.97 |
| EPS actual | $19.39 |
| EPS surprise | 94.48% |
| Date | Price |
|---|---|
| Oct 22, 2025 | $16.97 |
| Oct 23, 2025 | $16.97 |
| Oct 24, 2025 | $17.17 |
| Oct 27, 2025 | $17.11 |
| Oct 28, 2025 | $16.97 |
| Oct 29, 2025 | $16.85 |
| Oct 30, 2025 | $16.72 |
| Oct 31, 2025 | $16.72 |
| Nov 03, 2025 | $16.69 |
| 4 days before | 0% |
| 4 days after | -1.65% |
| On release day | -0.707% |
| Change in period | -1.65% |
Renaissancere Holdings Earnings Call Transcript Summary of Q3 2025
RenaissanceRe reported a very strong Q3 2025: operating income of $734 million, operating ROAE of 28% for the quarter (17% year-to-date), and record operating EPS of $15.62. Tangible book value per share plus change in accumulated dividends rose ~10% in the quarter and ~22% year-to-date. The company’s performance is driven by three stable profit pillars: disciplined underwriting (notably a large, high‑margin property catastrophe portfolio), growing capital partner fees (now ~ $300M annualized), and materially higher retained investment income (retained NII up from $392M in 2022 to ~ $1.2B trailing 4 quarters). Management grew property CAT capacity materially since 2022, preserved underwriting margins (avg ~50% combined ratio in property CAT since 2023), and returned significant capital to shareholders (~$1B repurchased YTD). Looking to 2026, RenaissanceRe expects some rate pressure (management cites ~10% baseline decline in property CAT pricing at Jan 1), continued competition but still attractive rate adequacy, and a deliberate focus on margin over top-line growth. Casualty remains carefully managed (selective pullbacks in U.S. general liability) until sustained improvement in claims trends is evident. Investment positioning (including derivatives and a strategic gold allocation) and fee‑generating third‑party capital are described as durable contributors to earnings stability. Capital management remains active: management expects continued buybacks given excess capital and attractive share value, while deploying capital selectively into profitable property CAT opportunities.
Sign In
Buy RNR-PG